Eisai Launches PPI/Antibiotics Pack For H. Pylori In Japan
This article was originally published in PharmAsia News
Executive Summary
Eisai will launch a package containing two antibiotic components and the proton pump inhibitor Pariet for the eradication of helicobacter pylori, one of the causes of gastric cancer and gastric ulcers.